Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use

Ch-mAb7F9, a human-mouse chimeric monoclonal antibody (mAb) designed to bind (+)-methamphetamine (METH) with high affinity and specificity, was produced as a treatment medication for METH abuse. In these studies, we present the preclinical characterization that provided predictive evidence that ch-m...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevens, Misty W, Tawney, Rachel L, West, C Michael, Kight, Alicia D, Henry, Ralph L, Owens, S Michael, Gentry, W Brooks
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984342/
https://www.ncbi.nlm.nih.gov/pubmed/24492290
http://dx.doi.org/10.4161/mabs.27620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984342/
https://www.ncbi.nlm.nih.gov/pubmed/24492290
http://dx.doi.org/10.4161/mabs.27620

Ejemplares similares